Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-055665
Filing Date
2026-05-05
Accepted
2026-05-05 16:28:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2613419-1_424b5.htm 424B5 604529
2 GRAPHIC lg_avalotherapeitocs-bw.jpg GRAPHIC 11417
3 GRAPHIC tb_companyoverview-4c.jpg GRAPHIC 29080
  Complete submission text file 0001104659-26-055665.txt   661739
Mailing Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087
Business Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-292614 | Film No.: 26943716
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)